The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic and proteomic analysis of patient tumors for molecular target selection.
 
Shiva Sreenath Andrali
No Relationships to Disclose
 
Erlinda Maria Gordon
No Relationships to Disclose
 
Sandeep K. Reddy
Employment - Caris Life Sciences; NantHealth
Leadership - Caris Life Sciences; NantHealth
Stock and Other Ownership Interests - Caris Life Sciences; NantHealth
Speakers' Bureau - Merck
Patents, Royalties, Other Intellectual Property - Patent WO/2016/141169; Patent WO/2016/141169
 
SHANKAR SELLAPPAN
Employment - NantWorks
Stock and Other Ownership Interests - NantWorks; OncoPlex Diagnostics; Qiagen
Research Funding - NantWorks
Patents, Royalties, Other Intellectual Property - For a biomarker signature for response to treatment in lung cancer.
Travel, Accommodations, Expenses - NantWorks
 
John Chang
No Relationships to Disclose
 
Esha Sachdev
No Relationships to Disclose
 
Sant P. Chawla
Honoraria - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Consulting or Advisory Role - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Speakers' Bureau - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Research Funding - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma